calendar system used by Janssen and each of its Affiliates for internal business purposes (a copy of which calendar for 2019 and 2020 is attached hereto as Schedule 1.16), such that each Calendar Quarter ends on the last date of the calendar quarter indicated on Schedule 1.16 (the "Quarter End Date") and begins on the date following the Quarter End Date of the preceding Calendar Quarter. 1.17 "Calendar Year" means a calendar year based on that certain universal calendar system used by Janssen and each of its Affiliates for internal business purposes (a copy of which calendar for 2019 and 2020 is attached hereto as Schedule 1.16), such that each Calendar Year ends on the fourth Quarter End Date for such year and begins on the date following the fourth Quarter End Date of the preceding Calendar Year. 1.18 "Call" means an in-person visit by an adequately trained sales representative to the office of a health care professional in the Territory for the purpose of promoting or presenting one or more pharmaceutical products. 1.19 "Call Plan" has the meaning set forth in Section 2.2.3. 1.20 "CPR Mediation Procedure" has the meaning set forth in Section 13.3.1. 1.21 "CPR Rules" has the meaning set forth in Section 13.4. 1.22 "Companion Diagnostic" means the diagnostic test approved by FDA concurrently with the Product for use in conjunction with the Product. 1.23 "Company" has the meaning set forth in the preamble to this Agreement. 1.24 "Company Indemnified Parties" has the meaning set forth in Section 12.1.1. 1.25 "Company Internal Detail Reporting System" means the data and records collected by Company and its Affiliates, in accordance with its standard business practice, to monitor Details made by Sales Representatives, which, with respect to the Product, include the date a Detail was made, the name of